Skip to main content

Advertisement

Table 1 Baseline and follow up demographic and clinical characteristics of HIV-associated TB patients and comparison of mortality, Serowe/Palapye district Botswana 2013

From: Human immunodeficiency virus-associated tuberculosis care in Botswana: evidence from a real-world setting

Variables Total N = 300 N (%) Died Total:45 N (%) Survivors Total:255 N (%) P
Age group, year
 < 35 104 (35) 15 (33) 89 (35)
 35–59 179 (60) 23 (51) 156 (61)
 ≥ 60 17 (6) 7 (16) 10 (4) 0.007
 Male sex 170 (57) 28 (62) 142 (56) 0.514
 Unemployeda 207 (69) 34 (76) 173 (68) 0.323
 Smokerb 6 (2) 3 (7) 3 (1) 0.008
 Body weightc < 50 kg 102 (34) 17 (38) 85 (33) 0.023
 Smear positive PTB 147 (49) 15 (33) 132 (52) 0.068
 Extrapulmonary 80 (27) 13 (29) 67 (26) 0.861
 Previous TB 34 (11) 4 (9) 30 (12) 0.799
 Feverd 127 (42) 23 (51) 104 (41) 0.323
 Productive coughd 212 (71) 31 (69) 181 (71) 0.863
 Night sweatsd 92 (30.7) 9 (20) 83 (33) 0.238
 Loss of weightd 180 (60) 33 (73) 147 (58) 0.069
 Duration of symptoms > 3 monthsd 44 (15) 7 (16) 37 (15) 0.509
 No ART use during TB treatment 43 (14) 15 (33) 28 (11) < 0.001
 ART naïve 83 (28) 18 (40) 65 (26) 0.045
 OI other than TB 19 (6) 12 (27) 7 (3) < 0.001
 CD4 counts cells/μl at TBe < 200 111 (37) 21 (47) 90 (35) 0.086
 Hemoglobinf < 10 g/dl 85 (28) 22 (49) 63 (25) 0.004
 Major Side effect 9 (3) 5 (11) 4 (2) 0.003
 Diabetes mellitus 5 (2) 0 5 (2) 1
 Cotrimoxazole prophylaxis 300 (100) 45 (100) 255 (100) 1
  1. TB tuberculosis, ART antiretroviral therapy, IRIS immune reconstitution inflammatory syndrome;
  2. Major side effect which were found included Hepatoxicity (8/9), and Stevens Johnson syndrome 1/9 OI: opportunistic infection
  3. a missing data for 22 patients (7.3%)
  4. b missing data for 125 patients (41.7%)
  5. c missing data for 87 patients (29%)
  6. d missing data for 21 to 25 patients (7 to 8.3%)
  7. emissing data for 57 (19%)
  8. f missing data for 84 patients (28%)